Depression SSNRI Drugs
The selective serotonin norepinephrine reuptake inhibitors (SSNRI) are a class of antidepressant medications that were developed after the selective serotonin reuptake inhibitors (SSRI). SSNRI medications inhibit both the reuptake of serotonin and norepinephrine in the synaptic space. This has the effect of increasing the concentration of both of these neurotransmitters, and ultimately, reducing depression.
Examples of SSNRI drugs include:
Continue to Depression SSRI Drugs
- Badamgarav E, Weingarten SR, Henning JM, Knight K, Hasselblad V, Gano A Jr, Ofman JJ. Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry. 2003 Dec;160(12):2080-90. 
- Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003 Nov 10;163(20):2433-45. 
- Barrett B, Byford S, Knapp M. Evidence of cost-effective treatments for depression: a systematic review. J Affect Disord. 2005 Jan;84(1):1-13. 
- Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G. Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials. Med Care. 2004 Dec;42(12):1211-21. 
- Remick RA. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ. 2002 Nov 26;167(11):1253-60. 
- Wulsin LR. Is depression a major risk factor for coronary disease? A systematic review of the epidemiologic evidence. Harv Rev Psychiatry. 2004 Mar-Apr;12(2):79-93.